보도자료
Blue Note Therapeutics and Bixink Enter Licensing Agreement for attune™ and DreAMLand™, Prescription Digital Therapeutics for Mental Well-Being in Cancer Patients
Copyright 2020 - BIXINK | Terms of Use | Contact
서울특별시 강남구 논현로 561 6층 [06125]
6F, 561 Nonhyeon-ro, Gangnam-gu, Seoul 06125, Republic of Korea
https://www.globenewswire.com/news-release/2022/05/10/2439186/0/en/Blue-Note-Therapeutics-and-Bixink-Enter-Licensing-Agreement-for-attune-and-DreAMLand-Prescription-Digital-Therapeutics-for-Mental-Well-Being-in-Cancer-Patients.html